Health Care & Life Sciences » Biotechnology | Proteon Therapeutics Inc.

Proteon Therapeutics Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
5,191.00
83,595.00
65,263.00
41,317.00
42,141.00
21,867
Other Current Assets
139.00
1,006.00
1,345.00
1,438.00
1,339.00
1,369
Total Current Assets
5,330.00
84,601.00
66,608.00
42,755.00
43,480.00
23,236
Net Property, Plant & Equipment
62.00
83.00
224.00
372.00
259.00
263
Total Investments and Advances
-
-
-
14.00
22.00
-
Other Assets
-
114.00
706.00
379.00
218.00
22
Total Assets
5,659.00
84,798.00
67,538.00
43,520.00
43,979.00
23,521
ST Debt & Current Portion LT Debt
5,058.00
-
-
-
-
Accounts Payable
399.00
-
-
-
-
Income Tax Payable
267.00
-
-
-
-
Other Current Liabilities
4,044.00
2,338.00
4,133.00
5,079.00
9,240.00
Total Current Liabilities
9,768.00
2,338.00
4,133.00
5,079.00
9,240.00
Deferred Taxes
267.00
-
-
-
-
Total Liabilities
9,768.00
2,338.00
4,133.00
5,079.00
9,240.00
Common Equity (Total)
100,514.00
82,460.00
63,405.00
38,441.00
13,216.00
Total Shareholders' Equity
4,109.00
82,460.00
63,405.00
38,441.00
34,739.00
Total Equity
4,109.00
82,460.00
63,405.00
38,441.00
34,739.00
Liabilities & Shareholders' Equity
5,659.00
84,798.00
67,538.00
43,520.00
43,979.00
Preferred Stock (Carrying Value)
96,405.00
-
-
-
21,523.00

About Proteon Therapeutics

View Profile
Address
200 West Street
Waltham Massachusetts 02451
United States
Employees -
Website http://www.proteontherapeutics.com
Updated 07/08/2019
Proteon Therapeutics, Inc. engages in the research and development of biopharmaceutical products. It produces and commercializes vonapanitase for the treatment of renal and vascular disease. The company was founded by F.